Seropositivity for MIA and S100 in patients with gastrointestinal carcinomas

Medical Oncology

Volumn 17, Issue 1, 2000, Pages 35-38

  Wagner, Volker ^a   Rudi, J ^a   Naher H ^a   Stremmel, W ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

ELISA; Gastrointestinal carcinomas; Melanoma inhibiting activity; S100; Tumor marker

Indexed keywords

PROTEIN S 100; TUMOR MARKER;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER PALLIATIVE THERAPY; COLORECTAL CARCINOMA; CONTROLLED STUDY; FEMALE; GALLBLADDER CARCINOMA; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MELANOMA; PANCREAS CANCER; PRIORITY JOURNAL; STOMACH CANCER;

EID: 0034071159     PISSN: 07360118     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02826214     Document Type: Article

References (24)

1. 1 Guo HB et al. Clinical significance of serum S100 in metastatic malignant melanoma. Eur J Cancer 1995; 31A: 1898-1902.
2. 2 Bosserhoff AK et al. Melanoma-inhibiting activity, a novel serum marker for progression of malignant melanoma. Cancer Res 1997; 57: 3149-3153.
3. 3 Miliotes G et al. Evaluation of new putative tumor markers for melanoma. Ann Surg Oncol 1996; 3: 558-563.
4. 4 Von Schoultz E et al. Prognostic value of serum analyses of S100b protein in malignant melanoma. Melanoma Res 1996; 6: 133-137.
5. 5 Deichmann M et al. S100β, MIA and LDH discriminate progressive from non-progressive AJCC stage IV melanoma disease. J Clin Oncol 1999; accepted for publication.
6. 6 Dietz U, Sandell LJ. Cloning of a retinoic acid-sensitive mRNA expressed in cartilage and during chondrogenesis. J Biol Chem 1996; 271: 3311-3316.
7. 7 Isobe T, Ishioka N, Okuyama T. Structural relation of two S-100 proteins in bovine brain; subunit composition of S-100a protein. Eur J Biochem 1981; 115: 469-474.
8. 8 Isobe T, Takahashi K, Okuyama T. S-100a protein is present in neurons of central and peripheral nervous system. J Neurochem 1984; 43: 1494-1496.
9. 9 Nakajima T, Sato Y, Watanabe S, Sakurai M, Hidaka H. Immunoelectron microscopical demonstration of S100 protein in epidermal Langerhans cells. Biomed Res 1982; 8: 226-231.
10. 10 Stefansson K, Wollman R, Jerkovic M. S100 protein in tissue tumors derived from Schwann cells and melanocytes. Pathology 1982; 106: 261-268.
11. 11 Hidaka H et al. Purification and characterization of adipose tissue S100b protein. J Biol Chem 1985; 258: 2705-2709.
12. 12 Kato K, Kimura S. S100a protein is mainly located in the heart and striated muscles. Biochim Biophys Acta 1985; 842: 146-150.
13. 13 Semba R, Kato K, Isobe T, Kashiwamata S. Purification of S100a protein from rat kidney. Brain Res 1987; 401: 9-13.
14. 14 Mokuno K et al. Neuron-specific enolase and S-100 protein levels in cerebrospinal fluid of patients with various neurological diseases. J Neurol Sci 1983; 60: 443-451.
15. 15 Persson L et al. S-100 protein and neuronspecific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system. Stroke 1987; 18: 911-918.
16. 16 Fagnart O, Sindic C, Laterre C. Particle counting immunoassay of S-100 protein in serum. Possible relevance in tumors and ischemic disorders of the central nervous system. Clin Chem 1988; 34: 1387-1391.
17. 17 Aurell A, Rosengren LE, Wikkelsö C, Nordberg G, Haglid KG. The S-100 protein in cerebrospinal fluid: a simple ELISA method. J Neurol Sci 1989; 89: 157-164.
18. 18 Aurell A et al. Determination of S-100 and GFA protein concentrations in cerebrospinal fluid after brain infarction. Stroke 1991; 22: 1254-1258.
19. 19 Hardemark HG et al. S-100 protein and neuron-specific enolase in CSF after experimental traumatic or focal ischemic brain damage. J Neurosurg 1989; 71: 727-731.
20. 20 Ingebrigtsen T, Romner B, Kongstad P, Langbakk B. Increased serum concentrations of protein S-100 after minor head injury: a biochemical serum marker with prognostic value? J Neurol Neurosurg Psychiatry 1995; 59: 103-104.
21. 21 Johnsson P et al. Cerebral complications after cardiac surgery assessed by S-100 and NSE levels in blood. J Cardiothorac Vasc Anesth 1995; 9: 1-7.
22. 22 Gaynor R et al. S100 protein: a marker for human malignant melanomas? Lancet 1981; 1: 869-871.
23. 23 Drier JK, Swanson PE, Cherwitz DL, Wick MR. S100 protein immune-reactivity in poorly differentiated carcinomas. Immunohistochemical comparison with malignant melanoma. Arch Pathol Lab Med 1987; 111: 447-452.
24. 24 Hancock C, Allen BC, Herrera GA. HMB-45 detection in adenocarcinomas. Arch Pathol Lab Med 1991; 115: 886-890.